everyone, morning, Thanks, Scott. in your for interest thank Good and you Avanos.
results continue per enterprise, the responded to pandemic. patients customers. current review we I'll for earnings the the pleased meet before see we with as have brief our needs million earned our brought pandemic, of for achieved and XXX begin elective our While share. against how our and of environment progress XXXX and to teams the $X.XX a with the our priorities. quarter sales the matter, our we chain, quarter dynamics on relates to to of diluted very discussing of we're adjusted remain that things the We and the on the getting surgeries, it Across shortages, as of impacts back supply hospital staff challenging operational focused by commercial
slowdown we during were the Our with year. in results categories as sales other sales delivered On-Q, the in planning results our the electives our quarter line pushing of during and of third we each through the the summer, with the sales experienced solid out result than in nine primarily product Delta variant months Other first assumption. a of
XX in versus As last margin quarter, profile improvement margins we third Gross the anticipated the better were for gross or the with meaningful throughout quarter. September third our points noted a second August both for we basis quarter, margins and quarter. XX%, XX% exceeding gross
improve Our will quarter gross to margins continue and stabilize throughout XXXX. the fourth into
other to and determine we inflationary in transportation further the improvement short and will unable pressures therefore, However, are we remain, see much how chain term. supply
primarily margin transitory, As operating pandemic We last our these being of and quarter, across permanent we remain mentioned not gross that do headwinds, in are industries, impacting to indicate structure. our assessment. confident a driven, seen most change
throughout efficiencies continuing improve, to our revenue market on can additional being meaningfully Although, percentage the environment as SG&A, on an a commitment have a that business ways a provide basis. on as on this and deliver continue internal expenses. that progress and gross our projections will are our a XXXX to reduce we cost our to exit background, improved Teams current we lower priorities. year, to and With operating profit, have the therefore to discussion as behind update structure on find increase ensuring are than gross of margins of go-forward less we productivity and our move against XX% let's identified
of product solid portfolio. delivered we outcomes As most revenue our mentioned across earlier,
globally up was North in America. X% NeoMed by versus led business prior and health digestive over Our X% year,
the the suction our last ventilation were third to Our for the procedures Sequentially, patients to of million mechanical with prior before received in year, standard sales. year, flat contributed the which moving the needing catheter pandemic push non-invasive we versus quarter systems care business hospitalization was related of primarily down of primarily we the ventilation. respiratory X related quarter, second coronavirus as has to versus shifted closed due additional to
interventional On management the and due pain X% little growth from side, On-Q impacting saw almost then the we franchise. related Pain our a over procedures portfolio, X% pause, surgical was while acute elective our to pain down Delta
and procedural on said, conversations for the also full have levels its for volume are we recovery for administrators, quarter our past similar being As to second as believe in we franchise the of surgeons revenue. to inpatient On-Q will hospital anticipate well as with remain sequential stated foreseeable based peers disclosing, quarters That quarter, do our what the future. potential we below our growth and fourth continue
into we continue improve care year, to use product offerings and As the of move enhance the our of quarter for our the last we to ease partners. efficacy
strengthened the increased in experience physician, and business, patient vehicle of a physicians ambIT collection and differentiated direct Pain to questions between premium also and a those patients and new an generator, radio position. launched have. the kits now to associated full education providing last COOLIEF's us active levels the outcomes COOLIEF RF launch procedures, new our patients' by with but of app giving recently understand the feel. new satisfaction pump real the physician feedback On-Q also completed might easier from improve give helps improvement and Block data look engage we abstracts They've manufacturing more track Pro, successfully about The perform monitor cooled patient our to time. probe on patient probes, place through recovery to to high maintaining the next-generation QX. for cooled pain of launch our leadership margins. already and - gross For launch Within improve margin feedback our avenue a probe and limited gross while make in it efficiencies frequency their get Combined for QX, for year, the our in COOLIEF, There which probes kits we is supports with new our
partners agreements, we - leverage from where orthopedic We surgeons. see access channel orthopedic continue our also sales to to to momentum gain partnership for building
electronic we're positive setting, capture across into our across positioning is franchise, accelerating our hardware CorTrak our the to to the continues. ambIT Shifting care which record while of Finally, of Chronic is levels. ambulatory for Care, double-digit procedure to digestive strategy sales health additional us our growth delivering our pump trend maintained surgical Corpak volumes. We franchise NeoMed standard
our I the given health down tailwind. prior pandemic sales stated As earlier, were respiratory year
higher currently flu catheter and our year season of We this have we experienced that activity with suction for levels buying nominal any consistent for products. modeling, closed modeled have a not
margin gross Our since throughout We improving fourth and in focused our the pandemic and operating these pleased quarter. some of the further very our the area progress margins. start quarter, XXXX focus second initiatives. were of with remain as recapturing meaningful in on exit relates we gross We margin on made the to QX gains improvements, loss, gross anticipating
we the XXs. are gross work remains also these transitory, confident to noted margin and margin our back XXs but are headwinds to up low recognize profile gross high As earlier, get a significant
support We and of repeatable fourth third of $XX flow flow. the Our quarter, will refunds free free during working to cash which our remaining Act quarter current $XX $XX consistent the generated and litigation. related $XX cash the operating this partially some of million consistent offset CARES repeatable is generating that tax DOJ cash received with second million anticipate again free sell was flow. upside to capital The for we generating cash the improved quarter. in and generating quarter, coupled the million the by free to paid we outstanding million priority flow results, priority in begin positive We
year the capital for priority on last Our deployment. focuses
are remains and of targets, potential generate our line leverage with healthy, we and meaningfully, improve enhance tuck-in our margin in existing engaged active dialog our a top pipeline growth, synergies, M&A which footprint, would profile. Our number
disciplined identifying remain well that return capital. targets generate meet a in both initiatives, as will strong financial ensuring on as our our strategic we hurdles exceed We
a as XXXX. each strategies we to XXXX meet We well material cash begin as value last this while to shares, of will flow Kimberly-Clark, up perspective. legal product outcome frees to a IP from to the a DOJ dispute with for resolved have regards expenses reduce positive each areas of across of only range quarters, M&A, and has internal investigation, with to four complete cases. This with to indemnification us, also with as infringement our significantly to funding look it well be over uncertainty our litigation, smaller other including and remain positions Lastly, more aggressive these capital we Not positioned the our the Medtronic but reduced we all advance continue repurchase liability creation, us of case toward four ensuring outstanding needs. our our
turn Now, the over Michael. call I'll to